These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3046969)

  • 21. In vitro natural killer cell activity in the spontaneously diabetic BB/Wor rat: effects of serum on lysis of insulinoma cells.
    Koevary SB
    Diabetes Res; 1988 Jun; 8(2):77-84. PubMed ID: 2852569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.
    Kappelle AC; Biessels G; Bravenboer B; van Buren T; Traber J; de Wildt DJ; Gispen WH
    Br J Pharmacol; 1994 Mar; 111(3):887-93. PubMed ID: 8019766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of irradiation on diabetes in the BB/Wor rat.
    Handler ES; Mordes JP; McKeever U; Nakamura N; Bernhard J; Greiner DL; Rossini AA
    Autoimmunity; 1989; 4(1-2):21-30. PubMed ID: 2491639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The BB rat as a model of human insulin-dependent diabetes mellitus.
    Whalen BJ; Mordes JP; Rossini AA
    Curr Protoc Immunol; 2001 May; Chapter 15():15.3.1-15.3.15. PubMed ID: 18432735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular smooth muscle cells (VSMC) proliferation of streptozotocin-diabetic animals induced by diadenosine polyphosphates.
    Verspohl EJ; Hagemann J; Lempka M
    Exp Clin Endocrinol Diabetes; 2004 Mar; 112(3):142-7. PubMed ID: 15052534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
    Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Zhang W; Sima AA
    J Neuropathol Exp Neurol; 2004 May; 63(5):450-60. PubMed ID: 15198124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of impaired insulin/IGF action in primary diabetic encephalopathy.
    Li ZG; Zhang W; Sima AA
    Brain Res; 2005 Mar; 1037(1-2):12-24. PubMed ID: 15777748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
    Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
    Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus.
    Tirabassi RS; Flanagan JF; Wu T; Kislauskis EH; Birckbichler PJ; Guberski DL
    ILAR J; 2004; 45(3):292-302. PubMed ID: 15229376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of rabbit aortic smooth muscle cell proliferation in diabetes mellitus.
    Alipui C; Ramos K; Tenner TE
    Cardiovasc Res; 1993 Jul; 27(7):1229-32. PubMed ID: 8252581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of KCa3.1 channels in proliferation and migration of vascular smooth muscle cells by diabetic rat serum.
    Su XL; Zhang H; Yu W; Wang S; Zhu WJ
    Chin J Physiol; 2013 Jun; 56(3):155-62. PubMed ID: 23656217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes.
    Yono M; Pouresmail M; Takahashi W; Flanagan JF; Weiss RM; Latifpour J
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):251-5. PubMed ID: 16235050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta.
    Yamaguchi H; Igarashi M; Hirata A; Sugae N; Tsuchiya H; Jimbu Y; Tominaga M; Kato T
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2095-101. PubMed ID: 15345514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-24 regulates vascular remodeling via inhibiting PDGF-BB pathway in diabetic rat model.
    Yang J; Zeng P; Yang J; Liu X; Ding J; Wang H; Chen L
    Gene; 2018 Jun; 659():67-76. PubMed ID: 29559348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
    Sima AA; Zhang W; Sugimoto K; Henry D; Li Z; Wahren J; Grunberger G
    Diabetologia; 2001 Jul; 44(7):889-97. PubMed ID: 11508275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration.
    Faries PL; Rohan DI; Takahara H; Wyers MC; Contreras MA; Quist WC; King GL; Logerfo FW
    J Vasc Surg; 2001 Mar; 33(3):601-7. PubMed ID: 11241133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelium-dependent relaxation to acetylcholine in the aorta of streptozotocin induced diabetic-rat and the BB-diabetic rat.
    Kappagoda T; Jayakody L; Rajotte R; Thomson AB; Senaratne MP
    Clin Invest Med; 1989 Jun; 12(3):187-93. PubMed ID: 2525976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acarbose on the development of diabetes in BB/Wor rats.
    Koevary SB
    Metabolism; 1990 Aug; 39(8):865-70. PubMed ID: 2377081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
    Kim TJ; Yun YP
    Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated.
    Koevary SB
    Diabetes Res; 1990 Mar; 13(3):133-8. PubMed ID: 2091881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.